Northwestern Mutual Wealth Management
MRNA icon

Northwestern Mutual Wealth Management’s Moderna MRNA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.01M Sell
14,469
-4,718
-25% -$244K ﹤0.01% 1394
2026
Q1 		$975K Buy
19,187
+3,806
+25% +$178K ﹤0.01% 1349
2025
Q4 		$454K Sell
15,381
-5,769
-27% -$157K ﹤0.01% 1577
2025
Q3 		$546K Sell
21,150
-13,249
-39% -$370K ﹤0.01% 1432
2025
Q2 		$949K Buy
34,399
+8,751
+34% +$230K ﹤0.01% 1183
2025
Q1 		$727K Buy
25,648
+5,560
+28% +$197K ﹤0.01% 1213
2024
Q4 		$835K Buy
20,088
+8,912
+80% +$426K ﹤0.01% 1129
2024
Q3 		$747K Sell
11,176
-756
-6% -$69.4K ﹤0.01% 1164
2024
Q2 		$1.42M Buy
11,932
+1,265
+12% +$160K ﹤0.01% 916
2024
Q1 		$1.14M Buy
10,667
+240
+2% +$24.2K ﹤0.01% 970
2023
Q4 		$1.04M Buy
10,427
+427
+4% +$35.9K ﹤0.01% 966
2023
Q3 		$1.03M Buy
10,000
+698
+8% +$77.9K ﹤0.01% 932
2023
Q2 		$1.13M Sell
9,302
-1,442
-13% -$192K ﹤0.01% 894
2023
Q1 		$1.65M Sell
10,744
-8,556
-44% -$1.41M ﹤0.01% 749
2022
Q4 		$3.47M Sell
19,300
-533
-3% -$87.2K 0.01% 539
2022
Q3 		$2.35M Sell
19,833
-513
-3% -$77.8K ﹤0.01% 587
2022
Q2 		$2.91M Buy
20,346
+13,572
+200% +$1.94M 0.01% 535
2022
Q1 		$1.17M Buy
6,774
+743
+12% +$125K ﹤0.01% 798
2021
Q4 		$1.53M Sell
6,031
-1,836
-23% -$537K ﹤0.01% 680
2021
Q3 		$3.03M Buy
7,867
+2,730
+53% +$1.01M 0.01% 481
2021
Q2 		$1.21M Sell
5,137
-1,613
-24% -$288K ﹤0.01% 699
2021
Q1 		$884K Buy
6,750
+718
+12% +$104K ﹤0.01% 748
2020
Q4 		$630K Buy
6,032
+2,570
+74% +$260K ﹤0.01% 765
2020
Q3 		$245K Buy
3,462
+3,262
+1,631% +$227K ﹤0.01% 960
2020
Q2 		$13K Sell
200
-1,300
-87% -$71.2K ﹤0.01% 1837
2020
Q1 		$45K Hold
1,500
– – ﹤0.01% 1430
2019
Q4 		$29K Hold
1,500
– – ﹤0.01% 1628
2019
Q3 		$24K Buy
1,500
+1,478
+6,718% +$21.8K ﹤0.01% 1680
2019
Q2 		$0 Buy
+22
New +$473 ﹤0.01% 2633

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Northwestern Mutual Wealth Management's MRNA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Moderna (MRNA) stake by 25% in Q2 2026, selling an estimated $244K and leaving 14,469 shares worth $1.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1394.

Northwestern Mutual Wealth Management first reported a position in MRNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $3.47M in Q4 2022. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Northwestern Mutual Wealth Management held 14,469 shares of Moderna worth $1.01M as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 4,718 Moderna shares in Q2 2026, an estimated $244K.
  • Moderna made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1394 holding.
  • Northwestern Mutual Wealth Management first reported a position in Moderna in Q2 2019 and has held it in 29 quarters since.
  • Northwestern Mutual Wealth Management's Moderna position peaked at $3.47M in Q4 2022.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.